RxDoctor Payments Data

Kenneth Alexander

Infectious Disease · Orlando, FLNPI 1962582031

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Merck accounts for 97.6% of it on its own, with 2 other manufacturers making up the rest. Among infectious disease clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$474,019in general payments, 2019–2025

Across 333 payments — averaging $1423.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$463K
  • Biofire Diagnostics, LLC$11K
  • Pfizer$94

What the payments were for

  • Consulting fees$23,1935%
  • Speaking & faculty fees$242,73851%
  • Travel & lodging$203,18243%
  • Food & beverage$4,9061%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck330$462,548
Biofire Diagnostics, LLC2$11,378
Pfizer1$94

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$474,019 in reported general payments places this provider in the 95th percentile of 669 infectious disease providers in Florida.

See all infectious disease providers in Florida →

Other infectious disease in Orlando

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →